The Effectiveness of Traditional Chinese Medicine Jinlida Granules on Glycemic Variability in Newly Diagnosed Type 2 Diabetes: A Double-Blinded, Randomized Trial
This study aimed to evaluate the influence of Jinlida granules on glycemic variability with or without metformin treatment in patients with newly diagnosed type 2 diabetes. This study was a 16-week, double-blinded, randomized, controlled clinical trial. The enrolled patients with newly diagnosed typ...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/2021/6303063 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850177674592387072 |
|---|---|
| author | Jiemin Pan Yuejie Xu Si Chen Yinfang Tu Yifei Mo Fei Gao Jian Zhou Cheng Hu Weiping Jia |
| author_facet | Jiemin Pan Yuejie Xu Si Chen Yinfang Tu Yifei Mo Fei Gao Jian Zhou Cheng Hu Weiping Jia |
| author_sort | Jiemin Pan |
| collection | DOAJ |
| description | This study aimed to evaluate the influence of Jinlida granules on glycemic variability with or without metformin treatment in patients with newly diagnosed type 2 diabetes. This study was a 16-week, double-blinded, randomized, controlled clinical trial. The enrolled patients with newly diagnosed type 2 diabetes were randomly divided into four groups: control, Jinlida, metformin, and combination treatment groups. A retrospective continuous glucose monitoring (CGM) system was used for subcutaneous interstitial glucose monitoring for 3 days consecutively. Hemoglobin A1c (HbA1c), traditional Chinese medicine symptom score, and CGM parameters, including glucose coefficient of variation, standard deviation of blood glucose values, and time in range of glucose 3.9–10.0 mmol/L, were assessed pre-test and post-test. A total of 138 participants completed the entire procedure. Compared with the pre-test, fasting plasma glucose, 2 hour postprandial plasma glucose, HbA1c, and traditional Chinese medicine symptom score all decreased in the four groups at the end of the test, and the combination treatment group showed the most significant decrease. In terms of CGM parameters, time in range of the Jinlida and metformin groups improved after intervention compared with the baseline (Jinlida group: 78.68 ± 26.15 versus 55.47 ± 33.29; metformin group: 87.29 ± 12.21 vs. 75.44 ± 25.42; P < 0.01). Additionally, only the Jinlida group showed decreased glucose standard deviation after intervention (1.57 ± 0.61 vs. 1.96 ± 0.95; P < 0.01). Jinlida granules can improve glycemic control and glycemic variability in patients with newly diagnosed type 2 diabetes. Clinical trial registration number: ChiCTR-IOR-16009296. |
| format | Article |
| id | doaj-art-c36af6469f344400a33d6807525c51d6 |
| institution | OA Journals |
| issn | 2314-6745 2314-6753 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Diabetes Research |
| spelling | doaj-art-c36af6469f344400a33d6807525c51d62025-08-20T02:18:55ZengWileyJournal of Diabetes Research2314-67452314-67532021-01-01202110.1155/2021/63030636303063The Effectiveness of Traditional Chinese Medicine Jinlida Granules on Glycemic Variability in Newly Diagnosed Type 2 Diabetes: A Double-Blinded, Randomized TrialJiemin Pan0Yuejie Xu1Si Chen2Yinfang Tu3Yifei Mo4Fei Gao5Jian Zhou6Cheng Hu7Weiping Jia8Department of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200233, ChinaDepartment of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200233, ChinaDepartment of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200233, ChinaDepartment of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200233, ChinaDepartment of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200233, ChinaDepartment of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200233, ChinaDepartment of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200233, ChinaShanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, ChinaDepartment of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200233, ChinaThis study aimed to evaluate the influence of Jinlida granules on glycemic variability with or without metformin treatment in patients with newly diagnosed type 2 diabetes. This study was a 16-week, double-blinded, randomized, controlled clinical trial. The enrolled patients with newly diagnosed type 2 diabetes were randomly divided into four groups: control, Jinlida, metformin, and combination treatment groups. A retrospective continuous glucose monitoring (CGM) system was used for subcutaneous interstitial glucose monitoring for 3 days consecutively. Hemoglobin A1c (HbA1c), traditional Chinese medicine symptom score, and CGM parameters, including glucose coefficient of variation, standard deviation of blood glucose values, and time in range of glucose 3.9–10.0 mmol/L, were assessed pre-test and post-test. A total of 138 participants completed the entire procedure. Compared with the pre-test, fasting plasma glucose, 2 hour postprandial plasma glucose, HbA1c, and traditional Chinese medicine symptom score all decreased in the four groups at the end of the test, and the combination treatment group showed the most significant decrease. In terms of CGM parameters, time in range of the Jinlida and metformin groups improved after intervention compared with the baseline (Jinlida group: 78.68 ± 26.15 versus 55.47 ± 33.29; metformin group: 87.29 ± 12.21 vs. 75.44 ± 25.42; P < 0.01). Additionally, only the Jinlida group showed decreased glucose standard deviation after intervention (1.57 ± 0.61 vs. 1.96 ± 0.95; P < 0.01). Jinlida granules can improve glycemic control and glycemic variability in patients with newly diagnosed type 2 diabetes. Clinical trial registration number: ChiCTR-IOR-16009296.http://dx.doi.org/10.1155/2021/6303063 |
| spellingShingle | Jiemin Pan Yuejie Xu Si Chen Yinfang Tu Yifei Mo Fei Gao Jian Zhou Cheng Hu Weiping Jia The Effectiveness of Traditional Chinese Medicine Jinlida Granules on Glycemic Variability in Newly Diagnosed Type 2 Diabetes: A Double-Blinded, Randomized Trial Journal of Diabetes Research |
| title | The Effectiveness of Traditional Chinese Medicine Jinlida Granules on Glycemic Variability in Newly Diagnosed Type 2 Diabetes: A Double-Blinded, Randomized Trial |
| title_full | The Effectiveness of Traditional Chinese Medicine Jinlida Granules on Glycemic Variability in Newly Diagnosed Type 2 Diabetes: A Double-Blinded, Randomized Trial |
| title_fullStr | The Effectiveness of Traditional Chinese Medicine Jinlida Granules on Glycemic Variability in Newly Diagnosed Type 2 Diabetes: A Double-Blinded, Randomized Trial |
| title_full_unstemmed | The Effectiveness of Traditional Chinese Medicine Jinlida Granules on Glycemic Variability in Newly Diagnosed Type 2 Diabetes: A Double-Blinded, Randomized Trial |
| title_short | The Effectiveness of Traditional Chinese Medicine Jinlida Granules on Glycemic Variability in Newly Diagnosed Type 2 Diabetes: A Double-Blinded, Randomized Trial |
| title_sort | effectiveness of traditional chinese medicine jinlida granules on glycemic variability in newly diagnosed type 2 diabetes a double blinded randomized trial |
| url | http://dx.doi.org/10.1155/2021/6303063 |
| work_keys_str_mv | AT jieminpan theeffectivenessoftraditionalchinesemedicinejinlidagranulesonglycemicvariabilityinnewlydiagnosedtype2diabetesadoubleblindedrandomizedtrial AT yuejiexu theeffectivenessoftraditionalchinesemedicinejinlidagranulesonglycemicvariabilityinnewlydiagnosedtype2diabetesadoubleblindedrandomizedtrial AT sichen theeffectivenessoftraditionalchinesemedicinejinlidagranulesonglycemicvariabilityinnewlydiagnosedtype2diabetesadoubleblindedrandomizedtrial AT yinfangtu theeffectivenessoftraditionalchinesemedicinejinlidagranulesonglycemicvariabilityinnewlydiagnosedtype2diabetesadoubleblindedrandomizedtrial AT yifeimo theeffectivenessoftraditionalchinesemedicinejinlidagranulesonglycemicvariabilityinnewlydiagnosedtype2diabetesadoubleblindedrandomizedtrial AT feigao theeffectivenessoftraditionalchinesemedicinejinlidagranulesonglycemicvariabilityinnewlydiagnosedtype2diabetesadoubleblindedrandomizedtrial AT jianzhou theeffectivenessoftraditionalchinesemedicinejinlidagranulesonglycemicvariabilityinnewlydiagnosedtype2diabetesadoubleblindedrandomizedtrial AT chenghu theeffectivenessoftraditionalchinesemedicinejinlidagranulesonglycemicvariabilityinnewlydiagnosedtype2diabetesadoubleblindedrandomizedtrial AT weipingjia theeffectivenessoftraditionalchinesemedicinejinlidagranulesonglycemicvariabilityinnewlydiagnosedtype2diabetesadoubleblindedrandomizedtrial AT jieminpan effectivenessoftraditionalchinesemedicinejinlidagranulesonglycemicvariabilityinnewlydiagnosedtype2diabetesadoubleblindedrandomizedtrial AT yuejiexu effectivenessoftraditionalchinesemedicinejinlidagranulesonglycemicvariabilityinnewlydiagnosedtype2diabetesadoubleblindedrandomizedtrial AT sichen effectivenessoftraditionalchinesemedicinejinlidagranulesonglycemicvariabilityinnewlydiagnosedtype2diabetesadoubleblindedrandomizedtrial AT yinfangtu effectivenessoftraditionalchinesemedicinejinlidagranulesonglycemicvariabilityinnewlydiagnosedtype2diabetesadoubleblindedrandomizedtrial AT yifeimo effectivenessoftraditionalchinesemedicinejinlidagranulesonglycemicvariabilityinnewlydiagnosedtype2diabetesadoubleblindedrandomizedtrial AT feigao effectivenessoftraditionalchinesemedicinejinlidagranulesonglycemicvariabilityinnewlydiagnosedtype2diabetesadoubleblindedrandomizedtrial AT jianzhou effectivenessoftraditionalchinesemedicinejinlidagranulesonglycemicvariabilityinnewlydiagnosedtype2diabetesadoubleblindedrandomizedtrial AT chenghu effectivenessoftraditionalchinesemedicinejinlidagranulesonglycemicvariabilityinnewlydiagnosedtype2diabetesadoubleblindedrandomizedtrial AT weipingjia effectivenessoftraditionalchinesemedicinejinlidagranulesonglycemicvariabilityinnewlydiagnosedtype2diabetesadoubleblindedrandomizedtrial |